Startup Doctolib’s Valuation Slides 38% in Secondary Share Sale

This is a live story built from multiple sources. It may evolve quickly.

Coverage meter • 1 min window

Back to home Open top source

B bloomberg.com

What’s included

Top recent items from this story.

1 items • 1 unique links

Bloomberg Technology 3 days ago • bloomberg.com

Startup Doctolib’s Valuation Slides 38% in Secondary Share Sale

Employees and early investors in French health-care startup Doctolib have sold shares in the company worth about €300 million ($345 million), the company said.

Open